Delivery Order SPE2DB25D3018-SPE2DB25FUYCE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a contract ceiling value of $31,642.05. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,309.59 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under a larger indefinite delivery contract (IDC) vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract is valued at $1,807.80 and utilizes firm fixed price terms. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and primary distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Jardiance 10 mg tablets in a 90-count package. This is a firm fixed-price delivery order with a ceiling value of $12,387.85 and an ultimate completion date of July 23, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and was awarded without a set-aside designation, indicating it was competed among...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $12,877.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The award represents a child delivery order issued under a larger contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,582.52 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This competitive award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's broader...
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Jardiance 25 mg tablets in a quantity of 90 units. This competitively awarded, non-set-aside contract carries a ceiling value of approximately $25,000 and features firm fixed pricing, with an ultimate completion date of August 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,560.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $1,530.68. This competitively awarded, firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract carries no set-aside designation, reflecting the...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB25FUYCEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Jardiance 25 mg tablets (90-count units) valued at $24,512.52. This firm fixed-price delivery order, with a completion date of July 30, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and operates as a prime contractor for the Defense Logistics Agency's Medical Supply Chain. This delivery order functions as a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery/Indefinite Quantity (IDIQ) agreement with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDIQ serves as a comprehensive global pharmaceutical support vehicle enabling supply of a wide range of medications, including specialty drugs, brand-name and generic pharmaceuticals, vaccines, and medical supplies to support military healthcare programs worldwide. The Jardiance delivery represents a portion of the company's extensive portfolio supplying critical medications to defense and veteran healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.5k | 7/29/25 |